These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21182150)

  • 1. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project.
    Coloma PM; Schuemie MJ; Trifirò G; Gini R; Herings R; Hippisley-Cox J; Mazzaglia G; Giaquinto C; Corrao G; Pedersen L; van der Lei J; Sturkenboom M;
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):1-11. PubMed ID: 21182150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.
    Trifirò G; Patadia V; Schuemie MJ; Coloma PM; Gini R; Herings R; Hippisley-Cox J; Mazzaglia G; Giaquinto C; Scotti L; Pedersen L; Avillach P; Sturkenboom MC; van der Lei J; Eu-Adr Group
    Stud Health Technol Inform; 2011; 166():25-30. PubMed ID: 21685607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
    Trifirò G; Coloma PM; Rijnbeek PR; Romio S; Mosseveld B; Weibel D; Bonhoeffer J; Schuemie M; van der Lei J; Sturkenboom M
    J Intern Med; 2014 Jun; 275(6):551-61. PubMed ID: 24635221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project.
    Avillach P; Mougin F; Joubert M; Thiessard F; Pariente A; Dufour JC; Trifirò G; Polimeni G; Catania MA; Giaquinto C; Mazzaglia G; Baio G; Herings R; Gini R; Hippisley-Cox J; Molokhia M; Pedersen L; Fourrier-Réglat A; Sturkenboom M; Fieschi M
    Stud Health Technol Inform; 2009; 150():190-4. PubMed ID: 19745295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
    Trifirò G; Pariente A; Coloma PM; Kors JA; Polimeni G; Miremont-Salamé G; Catania MA; Salvo F; David A; Moore N; Caputi AP; Sturkenboom M; Molokhia M; Hippisley-Cox J; Acedo CD; van der Lei J; Fourrier-Reglat A;
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1176-84. PubMed ID: 19757412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of adverse drug reaction signals using an electronic health records database: Comparison of the Laboratory Extreme Abnormality Ratio (CLEAR) algorithm.
    Yoon D; Park MY; Choi NK; Park BJ; Kim JH; Park RW
    Clin Pharmacol Ther; 2012 Mar; 91(3):467-74. PubMed ID: 22237257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems.
    Glasser SP; Salas M; Delzell E
    J Clin Pharmacol; 2007 Sep; 47(9):1074-86. PubMed ID: 17766697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug safety. Gaps in the safety net.
    Couzin J
    Science; 2005 Jan; 307(5707):196-8. PubMed ID: 15653480
    [No Abstract]   [Full Text] [Related]  

  • 9. The EU-ADR project: preliminary results and perspective.
    Trifiro G; Fourrier-Reglat A; Sturkenboom MC; Díaz Acedo C; Van Der Lei J;
    Stud Health Technol Inform; 2009; 148():43-9. PubMed ID: 19745234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.
    Bennett CL; Nebeker JR; Yarnold PR; Tigue CC; Dorr DA; McKoy JM; Edwards BJ; Hurdle JF; West DP; Lau DT; Angelotta C; Weitzman SA; Belknap SM; Djulbegovic B; Tallman MS; Kuzel TM; Benson AB; Evens A; Trifilio SM; Courtney DM; Raisch DW
    Arch Intern Med; 2007 May; 167(10):1041-9. PubMed ID: 17533207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic healthcare databases for active drug safety surveillance: is there enough leverage?
    Coloma PM; Trifirò G; Schuemie MJ; Gini R; Herings R; Hippisley-Cox J; Mazzaglia G; Picelli G; Corrao G; Pedersen L; van der Lei J; Sturkenboom M;
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):611-21. PubMed ID: 22315152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system.
    Rassen JA; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():41-9. PubMed ID: 22262592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of a semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European EU-ADR project.
    Avillach P; Joubert M; Thiessard F; Trifirò G; Dufour JC; Pariente A; Mougin F; Polimeni G; Catania MA; Giaquinto C; Mazzaglia G; Fornari C; Herings R; Gini R; Hippisley-Cox J; Molokhia M; Pedersen L; Fourrier-Réglat A; Sturkenboom M; Fieschi M
    Stud Health Technol Inform; 2010; 160(Pt 2):1085-9. PubMed ID: 20841851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short patent lives jeopardize drug and patient safety.
    Hondeghem LM; De Clerck F; Camm J
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):353-7. PubMed ID: 18049301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International reporting on adverse drug reactions: the CIOMS project. CIOMS ADR Working Group.
    Faich GA; Castle W; Bankowski Z
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):133-8. PubMed ID: 2338366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project.
    Avillach P; Coloma PM; Gini R; Schuemie M; Mougin F; Dufour JC; Mazzaglia G; Giaquinto C; Fornari C; Herings R; Molokhia M; Pedersen L; Fourrier-Réglat A; Fieschi M; Sturkenboom M; van der Lei J; Pariente A; Trifirò G;
    J Am Med Inform Assoc; 2013 Jan; 20(1):184-92. PubMed ID: 22955495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Databases for pediatric medicine research in Europe--assessment and critical appraisal.
    Neubert A; Sturkenboom MC; Murray ML; Verhamme KM; Nicolosi A; Giaquinto C; Ceci A; Wong IC;
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1155-67. PubMed ID: 18979461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research methods in drug surveillance.
    Engel RR; Grohmann R; Rüther E; Hippius H
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S12-5. PubMed ID: 15052510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should we react to adverse drug reactions?
    Ferner RE; Beard K
    Postgrad Med J; 2011 Feb; 87(1024):81-2. PubMed ID: 21303818
    [No Abstract]   [Full Text] [Related]  

  • 20. Collection and analysis of drug safety data in pregnancy.
    Moretti M
    Can J Clin Pharmacol; 2007; 14(1):e34-6. PubMed ID: 17213508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.